Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Neuropharmacology|December 2, 2021
Amylin Pharmacology in Alzheimer's Disease Pathogenesis and TreatmentRachel R Corrigan, Helen Piontkivska, Gemma CasadesusCurrent Pharmaceutical Design|March 20, 2020
The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's DiseaseSpencer Servizi, Rachel R Corrigan, Gemma CasadesusAnnual Review of Pathology|September 3, 2024
Somatic Mosaicism in Brain DisordersRachel R Corrigan, Lauren M Mashburn-Warren, Hyojung Yoon, et al.Journal of Alzheimer'S Disease : JAD|January 15, 2023
Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's DiseaseRachel R Corrigan, Luis Labrador, John Grizzanti, et al.Neurotrauma Reports|July 18, 2025
Early-Life Mild Traumatic Brain Injury Alters Neurodevelopment and Behavior in MiceRachel R Corrigan, Anna O Lanier, Emily S Dresher, et al.Neuroscience Letters|June 23, 2024
Loss of Slc35a2 alters development of the mouse cerebral cortexSoad Elziny, Sahibjot Sran, Hyojung Yoon, et al.Biorxiv : the Preprint Server for Biology|December 11, 2023
Loss of Slc35a2 alters development of the mouse cerebral cortexSoad Elziny, Sahibjot Sran, Hyojung Yoon, et al.Epilepsia|October 26, 2024
Mouse models of Slc35a2 brain mosaicism reveal mechanisms of mild malformations of cortical development with oligodendroglial hyperplasia in epilepsyHyojung Yoon, Amanda Ringland, James J Anderson, et al.Pageof 1